SAR and species/stereo-selective metabolism of the sorbitol dehydrogenase inhibitor, CP-470,711.

Article abstract of DOI:10.1016/S0960-894X(02)00208-1

SAR studies on the stereoisomers of CP-470,711 suggested that in vivo epimerization was taking place in rats. Further metabolism studies revealed that no epimerization was occurring in dogs, and that no epimerization was expected in humans. A mechanism for the in vivo epimerization is proposed involving an oxidation-reduction pathway of the secondary benzylic alcohol, in contrast to an acid/base-promoted epimerization of the same center during chemical synthesis.